A low expression of GPX3 was found to be a biomarker for poor prognosis in gallbladder cancer, and silencing GPX3 was found to promote tumor metastasis of thyroid cancer in which GPX3 functioned as a TSG [38,39]. Here, GPX3 is linked to thyroid gland carcinoma.